High expression of ACE2 in HER2 subtype of breast cancer is a marker of poor prognosis
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Cancer Treatment and Research Communications
- Vol. 27, 100321
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Angiotensin converting enzyme 2: A new important player in the regulation of glycemiaIUBMB Life, 2013
- Angiotensin-converting enzyme 2 attenuates the metastasis of non-small cell lung cancer through inhibition of epithelial-mesenchymal transitionOncology Reports, 2013
- Angiotensin‐(1‐7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt‐1The Prostate, 2012
- Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K/Akt and MAPK signaling pathwaysOncology Reports, 2011
- Angiotensin-Converting Enzyme Inhibitors and Cognitive Decline in Older Adults With HypertensionArchives of internal medicine (1960), 2009
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic SubtypesJournal of Clinical Oncology, 2009
- The emerging role of ACE2 in physiology and diseaseThe Journal of Pathology, 2007
- Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin IIAmerican Journal of Physiology-Renal Physiology, 2007
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- A Human Homolog of Angiotensin-converting EnzymeJournal of Biological Chemistry, 2000